Avancin 1g Infusion is a prescription antibiotic preparation containing vancomycin, a medicine belonging to the glycopeptide antibiotic class.
The product is supplied as a lyophilized powder for preparation of an intravenous infusion. The pictured carton contains one 1g vial and two 10ml containers of sterile water for injection.
Vancomycin is used in healthcare settings for selected serious bacterial infections caused by susceptible organisms, particularly certain Gram-positive bacteria.
Avancin must be prescribed, prepared and administered by qualified healthcare professionals according to the approved product instructions and institutional infection-control procedures.
Active Ingredient: Vancomycin.
Strength: 1g (1,000mg).
Medicine Class: Glycopeptide antibiotic.
Formulation: Lyophilized powder for solution for infusion.
Route: Intravenous infusion.
Pack Contents: One vial and two 10ml sterile-water containers.
Prescription Status: Rx Only.
Packaging Branding: Ferozsons Laboratories Limited and BSF Biosciences.
Intravenous vancomycin may be prescribed for serious infections caused by susceptible bacteria, including:
1. Serious Gram-Positive Bacterial Infections
Vancomycin may be used for certain serious infections involving susceptible Gram-positive organisms.
2. Methicillin-Resistant Staphylococcus aureus (MRSA)
Vancomycin is an established treatment option for selected serious MRSA infections when clinically appropriate.
3. Bloodstream Infections
Intravenous vancomycin may be prescribed for certain bacterial bloodstream infections under specialist medical supervision.
4. Infective Endocarditis
Vancomycin can be part of treatment for particular bacterial infections affecting the heart valves, depending on the organism and clinical guidance.
5. Bone, Joint and Other Serious Infections
Healthcare professionals may prescribe intravenous vancomycin for selected serious infections involving bone, joints or other tissues when the bacteria are susceptible.
The choice of antibiotic depends on the diagnosis, microbiological test results, susceptibility patterns and the patient's medical condition.
Vancomycin is not effective against viral illnesses such as influenza or the common cold.
Vancomycin inhibits bacterial cell-wall synthesis by binding to specific components involved in building the bacterial cell wall.
This action interferes with the growth and survival of susceptible bacteria.
The effectiveness of treatment depends on the type of infection, the causative organism, antibiotic susceptibility and appropriate medical management.
| Specification | Details |
|---|---|
| Brand | Avancin |
| Generic Name | Vancomycin |
| Strength | 1g |
| Formulation | Lyophilized powder |
| Preparation | Solution for infusion |
| Route | Intravenous |
| Pack | 1 Vial + 2 × 10ml Sterile Water |
| Medicine Class | Glycopeptide Antibiotic |
| Branding | Ferozsons / BSF Biosciences |
| Prescription | Required |
Avancin 1g is intended for administration by trained healthcare professionals only.
Use only with a valid medical prescription.
Follow the approved product leaflet and hospital procedures for preparation and administration.
Intravenous vancomycin requires appropriate dilution and controlled infusion.
The prescribed dose and treatment duration depend on infection severity, body weight, kidney function and clinical monitoring.
Healthcare professionals may monitor kidney function and vancomycin exposure during treatment.
Do not attempt to prepare, inject or administer this product without qualified medical supervision.
The supplied image is not sufficient to establish a complete preparation or dosing protocol.
Kidney Function
Vancomycin may cause kidney injury. Patients with kidney impairment or those receiving other potentially kidney-toxic medicines may require additional monitoring.
Infusion-Related Reactions
Vancomycin can cause infusion-related reactions, particularly when administered too rapidly. Symptoms may include flushing, itching, rash and blood-pressure changes.
Hearing Problems
Hearing-related adverse effects have been reported, especially in patients with additional risk factors.
Allergic Reactions
Do not administer to patients with a known serious hypersensitivity to vancomycin. Serious allergic reactions require emergency medical treatment.
Pregnancy and Breastfeeding
Use requires an individualized assessment by a qualified healthcare professional.
Antibiotic Resistance
Vancomycin should only be used when clinically indicated. Unnecessary antibiotic use contributes to antimicrobial resistance.
Reported adverse effects of intravenous vancomycin include:
Infusion-related flushing and itching.
Skin rash.
Pain or inflammation around the infusion site.
Kidney function changes.
Hearing-related symptoms.
Changes in blood cell counts.
Allergic reactions.
Rare but serious reactions can include acute kidney injury, severe skin reactions and anaphylaxis.
Healthcare professionals should monitor patients for clinically significant reactions throughout treatment.
Follow the storage instructions on the original Avancin carton and approved product leaflet.
Keep the product in its original packaging, protect it from unsuitable environmental conditions and keep it away from children.
Storage requirements after reconstitution or dilution must be determined from the approved product-specific instructions and institutional pharmacy procedures.
1. What is Avancin 1g?
Avancin 1g is a prescription intravenous antibiotic preparation containing vancomycin.
2. What is Avancin used for?
Intravenous vancomycin is used to treat selected serious infections caused by susceptible bacteria.
3. Is Avancin an antibiotic?
Yes. Vancomycin belongs to the glycopeptide group of antibiotics.
4. Does Avancin contain vancomycin?
Yes. The carton identifies vancomycin as its active ingredient.
5. What is the strength of Avancin?
The pictured product contains 1g of vancomycin per vial.
6. What comes inside the pack?
The pictured carton states one vial and two 10ml containers of sterile water for injection.
7. Can Avancin be used at home?
It requires professional preparation and intravenous administration. Any home-infusion arrangement must be supervised by an appropriately qualified healthcare service.
8. Is Avancin used for MRSA infections?
Intravenous vancomycin may be prescribed for certain serious MRSA infections when the organism is susceptible.
9. Is Avancin effective against viral infections?
No. Vancomycin is an antibacterial medicine and does not treat viral infections.
10. Can Avancin affect kidney function?
Yes. Vancomycin can cause kidney injury, and treatment may require kidney-function and drug-exposure monitoring.
11. How is Avancin administered?
The carton specifies intravenous use only. Preparation, dilution and infusion must be performed according to approved instructions by trained professionals.
12. Who is associated with the Avancin brand?
The supplied carton displays Ferozsons Laboratories Limited and BSF Biosciences branding. The exact manufacturing and marketing authorization roles should be verified from approved records.
Avancin 1g is a prescription-only injectable antibiotic intended for healthcare-professional administration.
This description provides general product identification and educational information. It does not replace an approved patient leaflet, prescribing information, microbiological testing, clinical judgment or hospital treatment protocols.
Dose selection, preparation, administration and monitoring must be determined by qualified healthcare professionals. Supply and advertising are subject to applicable Pakistani pharmaceutical regulations.